CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 12.95% on an annualized basis.
Buying $1,000 In CRSP: 5 years ago, an investor could have purchased 47.08 shares of CRISPR Therapeutics at the time with $1,000. This investment in CRSP would have produced an average annual return of 26.03%. Currently, CRISPR Therapeutics has a market capitalization of $4.83 billion.
CRISPR Therapeutics's Share Price Over Last 5 Years
This $1,000 investment would be worth $2,951.98 today based on a price of $62.72 for CRSP at the time of writing.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
